Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age

NCT00488345 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Infections
Intra-Abdominal Infection
Pneumonia, Bacterial
Skin Diseases, Bacterial
Skin Diseases, Infectious

Interventions

DRUG: Tygacil

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer